F8: Back to the future: how to mix the old and new treatments for SLE, Sjögren's and APS ...

Good correlation has been shown between pain scores derived from 4 different rating scales. The correlation was maintained when presentation of the scales was separated by a series of questions and by ...

Objectives This meta-analysis investigates the efficacy of tumour necrosis factor α (TNFα) blockers versus placebo for the treatment of ankylosing spondylitis (AS) and non-radiographic axial ...

Objectives Recent observational studies have highlighted the beneficial role of dairy ingestion in gout prevention. The aims of this study were to determine the acute effects of milk ingestion on ...

Background Microplastics (MPs) have been identified in different types of tissue, including lung, bowel, placenta and as well in human whole blood [1]. During analysis of synovial fluid samples with ...

Background Immunoadsorption (IAS) has been used to treat patients with SLE for many years. Efficacy was proved for case report or series with SLE after IAS treatment, while case-control studies are so ...

2 Azienda Zero, Veneto Region, Clinical governance Unit, Padua, Italy 3 Azienda Zero, Veneto Region, Epidemiological Department, Padua, Italy 4 Azienda Zero, Veneto Region, Clinical governance Unit, ...

Objectives To update the 2017 European Alliance of Associations for Rheumatology (EULAR) recommendations for treatment of systemic sclerosis (SSc), incorporating new evidence and therapies. Methods An ...

‘Poly-refractory’ disease affects 2.7% of patients with rheumatoid arthritis (RA) who have failed different groups of biologic disease-modifying antirheumatic drugs (b-DMARDS) and targeted synthetic ...

3 Centre de Recherche en Epidémiologie et Statistiques (CRESS), Unité Inserm 1153, Université Paris Cité, Paris, France ...

Background: Individuals with rheumatoid arthritis (RA) have an increased risk of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), compared with non-RA ...

Correspondence to Dr Liza Rajasekhar, Clinical Immunology and Rheumatology, Nizam's Institute of Medical Sciences, Hyderabad 500082, Telangana, India; lizarajasekhar{at}gmail.com We read with great ...